Estrella Immunopharma Warrant (ESLAW)

• Market cap: $222K
• 1 day: 0%
• 5 days: -22%
• 1 month: 10.99%
• 3 months: 17.51%
• 6 months: -55.36%
• Year to date: 62.34%
• 1 year: 19.19%
• 5 years: -72.22%
• 10 years: -72.22%
• Sector: Healthcare
• Industry: Biotechnology

About: Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.